These results suggest that although IFNγ-driven STAT1 activation modestly reduces the bioenergetic capacity and flexibility of breast cancer cells, these differences pale in comparison to the greater ability of phenformin to potentiate energetic and biosynthetic stress. This evidence concerns the gene STAT1 and breast cancer.